Legato Capital Management’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $301K | Hold |
9,622
| – | – | 0.04% | 498 |
|
|
2025
Q1 | $323K | Buy |
+9,622
| New | +$323K | 0.04% | 478 |
|
|
2024
Q2 | – | Sell |
-16,085
| Closed | -$692K | – | 630 |
|
|
2024
Q1 | $692K | Buy |
16,085
+4,248
| +36% | +$183K | 0.08% | 361 |
|
|
2023
Q4 | $545K | Buy |
11,837
+155
| +1% | +$7.14K | 0.07% | 398 |
|
|
2023
Q3 | $399K | Sell |
11,682
-628
| -5% | -$21.5K | 0.06% | 441 |
|
|
2023
Q2 | $474K | Buy |
+12,310
| New | +$474K | 0.06% | 432 |
|